Skip to main content
Header image

Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer

FAGERHOLM, R., K. SPROTT, T. HEIKKINEN, J. BARTKOVA, P. HEIKKILA, K. AITTOMAKI, J. BÁRTEK, D. WEAVER, C. BLOMQVIST, H. NEVANLINNA
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. Annals of Oncology. 2013, 24(11), 2780-2785, ISSN: 0923-7534, PMID: 23897704,